I-European Scientific Committee on Consumer Safety (SCCS) isanda kukhipha imibono yokuqala ngokuphepha kwe-ethylhexyl methoxycinnamate (EHMC) esetshenziselwa izimonyo. I-EHMC yisihlungi se-UV esisetshenziswa kakhulu, esisetshenziswa kakhulu emikhiqizweni yokuvikela ilanga.
Iziphetho eziyinhloko zimi kanje: I-1 SCCS ayikwazi ukunquma ukuthi ukusetshenziswa kwe-EHMC ekugxilweni okuphezulu kwe-10% kuzimonyo kuphephile yini. Isizathu siwukuthi idatha ekhona ayanele ukukhipha i-genotoxicity yayo. Kunobufakazi bokuthi i-EHMC inomsebenzi ophazamisa i-endocrine, okuhlanganisa umsebenzi obalulekile we-estrogenic kanye nomsebenzi obuthakathaka we-anti androgenic kukho kokubili ukuhlolwa kwe-vivo kanye ne-in vitro Ngenxa yezizathu ezingenhla, i-SCCS ayikwazi futhi ukunikeza ukuhlushwa okuphezulu okuphephile kwe-EHMC ukuze kusetshenziswe izimonyo. I-SCCS iveze ukuthi lokhu kuhlola akubandakanyi umthelela wokuphepha we-EHMC emvelweni.
Ulwazi olusemuva: I-EHMC okwamanje ivunyelwe ukusetshenziswa njengesithako sokuvikela ilanga emithethweni yezimonyo ye-EU, enokugxila okuphezulu okungu-10%. I-EHMC imunca kakhulu i-UVB futhi ayikwazi ukuvikela ku-UVA. I-EHMC inomlando omude wamashumi eminyaka wokusetshenziswa, njengoba ike yahlolwa ukuphepha ngo-1991, 1993, nango-2001. Ngo-2019, i-EHMC yafakwa ohlwini lokuhlola olubalulekile lwe-EU lwabaphazamisi be-endocrine abangaba ngu-28.
Umbono owandulelayo okwamanje ucelwa esidlangalaleni ukuba kuphawulwe ngawo, umnqamulajuqu wangoJanuwari 17, 2025. I-SCCS izohlola ngokusekelwe kumpendulo futhi ikhiphe umbono wokugcina esikhathini esizayo.
Lo mbono ungase uthinte imithetho yokusetshenziswa kwe-EHMC ku-EU cosmetics. U-Biwei uphakamisa ukuthi amabhizinisi afanelekile nabathengi kufanele baqaphe ngokucophelela inqubekelaphambili elandelayo.
Isikhathi sokuthumela: Nov-20-2024
